Valetudo Therapeutics LLC

Insider Reports History

Location
La Palma, CA
Signature
/s/ Chris Kim
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Valetudo Therapeutics LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Liminatus Pharma, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 6,169,406 $32,204,299 $5.22 30 Apr 2025 Direct

Insider Reports Filed by Valetudo Therapeutics LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LIMN Liminatus Pharma, Inc. 30 Apr 2025 0 $0 3 10%+ Owner 16 Jun 2025, 21:19